{"nctId":"NCT02447029","briefTitle":"Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial","startDateStruct":{"date":"2015-04"},"conditions":["Pregnancy, Unwanted"],"count":142,"armGroups":[{"label":"Active Comparator","type":"EXPERIMENTAL","interventionNames":["Drug: vaginal 2% Xylocaine"]},{"label":"standard lidocaine paracervical block","type":"OTHER","interventionNames":["Drug: standard lidocaine paracervical block"]}],"interventions":[{"name":"vaginal 2% Xylocaine","otherNames":[]},{"name":"standard lidocaine paracervical block","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n* Women ages 18 and older undergoing elective surgical abortion at 5 and 0/7 to 11 and 6/7 weeks gestational age\n* Use of IV sedation for pain management\n* English or Spanish speaking\n* Ability to give informed consent\n\nExclusion criteria:\n\n* Any pre-operative use of misoprostol (typically given at 12 weeks and above in this clinic)\n* Allergy to study medications: lidocaine, midazolam, fentanyl\n* Known uterine anomaly\n* Prior cervical surgery.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Difference in Pain Level at Time of Cervical Dilation as Measured by a Visual Analog Scale","description":"This is the amount of pain self-reported by the patient at the time of cervical dilation. VAS ranged from 0 to 100 mm, 0 equals no pain, 100 equals worse pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]}]},{"type":"SECONDARY","title":"Pain Level Prior to Procedure (Anticipated Pain) as Measured by a Visual Analog Scale","description":"This is the amount of pain self-reported by the patient prior to the procedure (Anticipated pain). VAS ranged from 0 to 100 mm, 0 equals no pain, 100 equals worse pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"56","spread":null}]}]}]},{"type":"SECONDARY","title":"Pain With Speculum Insertion as Measured by a Visual Analog Scale","description":"This is the amount of pain self-reported by the patient at the time of speculum insertion. VAS ranged from 0 to 100 mm, 0 equals no pain, 100 equals worse pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.5","spread":"18.4"},{"groupId":"OG001","value":"22.3","spread":"19.5"}]}]}]},{"type":"SECONDARY","title":"Pain With Tenaculum Placement as Measured by a Visual Analog Scale","description":"This is the amount of pain self-reported by the patient at the time of tenaculum placement. VAS ranged from 0 to 100 mm, 0 equals no pain, 100 equals worse pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.8","spread":"22.3"},{"groupId":"OG001","value":"32.4","spread":"24.3"}]}]}]},{"type":"SECONDARY","title":"Pain 30-45 Minutes After Procedure as Measured by a Visual Analog Scale","description":"This is the amount of pain self-reported by the patient 30-45 minutes after procedure. VAS ranged from 0 to 100 mm, 0 equals no pain, 100 equals worse pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"11.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Satisfaction With Procedure as Measured by a Visual Analog Scale","description":"This is the level of overall satisfaction self-reported by the patient at the completion of the procedure and prior to discharge. VAS ranged from 0 to 100 mm, 0 equals not satisfied, 100 equals highest satisfaction possible.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"86","spread":null},{"groupId":"OG001","value":"92.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Complication Rate as Measured by a Count of Participants in Each Group","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":69},"commonTop":[]}}}